- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04106583
Assessing the WAVE Extra Soft Coil in Intracranial Aneurysms and Comparing Imaging Modalities (SURF)
December 20, 2023 updated by: Penumbra Inc.
A Prospective, Multicenter Study Assessing the Embolization of Intracranial Aneurysms Using WAVE™ Extra Soft Coils, a Part of the Penumbra SMART COIL® System
The objective of this study is to demonstrate the safety and efficacy of the Penumbra SMART COIL® System, including the WAVE™ Extra Soft Coils (WAVE) as a fill and finish coil, in the treatment of intracranial aneurysms.
Imaging will be analyzed by an independent core lab to assess aneurysm occlusion rates and perform a comparative analysis between imaging modalities.
Study Overview
Status
Active, not recruiting
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
575
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Calgary, Canada, T2N 2T9
- Foothills Medical Center
-
Toronto, Canada, M5T 2S8
- University Health Network
-
-
-
-
-
Bremen, Germany
- Bremen-Mitte
-
Chemnitz, Germany, 09116
- Klinikum Chemnitz gGmbH
-
Lübeck, Germany, 23538
- UKSH - Campus Lübeck
-
-
-
-
-
Novara, Italy
- Maggiore della Carità
-
-
-
-
-
Barcelona, Spain
- Vall d'Hebron
-
San Sebastián, Spain
- Donostia
-
-
-
-
-
Basel, Switzerland
- Universitatsspital Basel
-
-
-
-
Alabama
-
Dothan, Alabama, United States, 36301
- Southeast Health Medical Center
-
-
Arizona
-
Tucson, Arizona, United States, 85719
- Banner UMC Tucson
-
-
California
-
La Mesa, California, United States, 91942
- Sharp Grossmont
-
Thousand Oaks, California, United States, 91360
- Los Robles
-
-
Colorado
-
Englewood, Colorado, United States, 80113
- HRI - Swedish
-
Lakewood, Colorado, United States, 80228
- St. Anthony's Hospital
-
-
Connecticut
-
New Haven, Connecticut, United States, 06320
- Yale New Haven
-
-
Florida
-
Miami, Florida, United States, 33136
- University of Miami (Jackson Memorial)
-
Tampa, Florida, United States, 33606
- University of South Florida
-
Tampa, Florida, United States, 33756
- Morton Plant
-
-
Illinois
-
Chicago, Illinois, United States, 60612
- Rush University Medical Center
-
Joliet, Illinois, United States, 60435
- AMITA Health
-
-
Indiana
-
Indianapolis, Indiana, United States, 46202
- Indiana University Health
-
-
Louisiana
-
New Orleans, Louisiana, United States, 70121
- Ochsner Medical Center
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02115
- Brigham and Women's Hospital
-
Boston, Massachusetts, United States, 02114
- Massachusetts General Hospital
-
-
Michigan
-
Wyoming, Michigan, United States, 49519
- Metro Health
-
-
Missouri
-
Bridgeton, Missouri, United States, 63044
- SSM Health Care
-
-
New York
-
Manhasset, New York, United States, 11030
- Northwell Health
-
New York, New York, United States, 10029
- Mount Sinai Hospital
-
Valhalla, New York, United States, 10595
- Westchester Medical Center
-
-
North Carolina
-
Greenville, North Carolina, United States, 27834
- Vidant Medical Center
-
-
Ohio
-
Toledo, Ohio, United States, 43608
- Mercy St. Vincent
-
-
Oklahoma
-
Oklahoma City, Oklahoma, United States, 73104
- University of Oklahoma
-
-
Pennsylvania
-
Danville, Pennsylvania, United States, 17822
- Geisinger Medical Center
-
Philadelphia, Pennsylvania, United States, 19104
- UPenn
-
Pittsburgh, Pennsylvania, United States, 15212
- Allegheny General Hospital
-
-
South Carolina
-
Charleston, South Carolina, United States, 29425
- MUSC
-
Greenville, South Carolina, United States, 29605
- Greenville Memorial Hospital
-
-
Tennessee
-
Knoxville, Tennessee, United States, 37996
- University of Tennessee Medical Center, Knoxville
-
-
Texas
-
Dallas, Texas, United States, 75246
- Baylor University Medical Center
-
McAllen, Texas, United States, 78503
- McAllen Medical Center
-
Plano, Texas, United States, 75075
- Texas Stroke Institute - DFW
-
-
Virginia
-
Newport News, Virginia, United States, 23601
- Riverside Regional Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
Patients with intracranial aneurysms treated with WAVE, as part of the Penumbra SMART COIL System
Description
Inclusion Criteria:
- Patient age ≥ 18 years
- Patient having embolization of intracranial aneurysms
- WAVE Extra Soft Coil is final finishing coil
- Penumbra SMART COIL System accounts for at least 75% of total number of coils implanted
- Informed consent obtained per IRB/EC requirements
Exclusion Criteria:
- Life expectancy less than 1 year
- Patient previously enrolled in the SURF Study
- Known multiple intracranial aneurysms requiring treatment during index procedure
- Patient is unwilling or unable to comply with protocol follow up schedule and/or based on the Investigator's judgment the patient is not a good study candidate
- Participation in an interventional drug or device study that may confound the results of the study
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Single Arm
Single Arm - Patients with intracranial aneurysms treated with WAVE, as part of the Penumbra SMART COIL System
|
WAVE, as part of the SMART COIL System
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Efficacy: Adequate Occlusion
Time Frame: Through Study Completion, An Average of 1 Year
|
Adequate occlusion defined as Raymond-Roy Class I and II at final follow-up Raymond-Roy Class grading ranges I to III higher values represent a worse outcome. |
Through Study Completion, An Average of 1 Year
|
Safety: Serious Adverse Events (SAEs)
Time Frame: Up to 24 Hours Post-Procedure
|
SAEs within 24 hours post-procedure
|
Up to 24 Hours Post-Procedure
|
Safety: Device-Related SAE
Time Frame: Through Discharge, up to 7 Days Post-Procedure
|
Device-related SAE up to 7 days or discharge
|
Through Discharge, up to 7 Days Post-Procedure
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Efficacy: Occlusion rate
Time Frame: Immediate Post-Procedure
|
Immediate post-procedure occlusion rates
|
Immediate Post-Procedure
|
Efficacy: Retreatment Rate
Time Frame: Through Study Completion, An Average of 1 Year
|
Retreatment rate at final follow-up
|
Through Study Completion, An Average of 1 Year
|
Efficacy: Aneurysm Occlusion Raymond I
Time Frame: Immediate Post-Treatment
|
Raymond-Roy Class grading ranges I to III higher values represent a worse outcome.
|
Immediate Post-Treatment
|
Efficacy: Aneurysm Occlusion Raymond I
Time Frame: Through Study Completion, An Average of 1 Year
|
Raymond-Roy Class grading ranges I to III higher values represent a worse outcome.
|
Through Study Completion, An Average of 1 Year
|
Efficacy: Aneurysm Recanalization or Progressive Thrombosis
Time Frame: From Immediate Post Procedure Through Study Completion, An Average of 1 Year
|
Aneurysm recanalization or progressive thrombosis from post procedure to final follow-up
|
From Immediate Post Procedure Through Study Completion, An Average of 1 Year
|
Safety: Major Ipsilateral Stroke
Time Frame: Through Study Completion, An Average of 1 Year
|
Occurrence of Major Ipsilateral Stroke
|
Through Study Completion, An Average of 1 Year
|
Safety: Device-Related SAE
Time Frame: Through Study Completion, An Average of 1 Year
|
Device related SAE at final follow-up
|
Through Study Completion, An Average of 1 Year
|
Safety: All-cause Morbidity and Mortality
Time Frame: Through Study Completion, An Average of 1 Year
|
All-cause morbidity and mortality at final follow-up
|
Through Study Completion, An Average of 1 Year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Clemens M Schirmer, MD, Geisinger Clinic
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 5, 2019
Primary Completion (Actual)
September 7, 2023
Study Completion (Estimated)
August 1, 2024
Study Registration Dates
First Submitted
September 25, 2019
First Submitted That Met QC Criteria
September 25, 2019
First Posted (Actual)
September 27, 2019
Study Record Updates
Last Update Posted (Estimated)
December 27, 2023
Last Update Submitted That Met QC Criteria
December 20, 2023
Last Verified
December 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CLP 13669
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Aneurysm, Brain
-
Centre hospitalier de l'Université de Montréal...RecruitingCerebral Aneurysm | Intracranial Aneurysm | Unruptured Cerebral Aneurysm | Brain Aneurysm | Ruptured Cerebral AneurysmCanada
-
Microvention-Terumo, Inc.Completed
-
Universitätsklinikum Hamburg-EppendorfRecruitingAneurysm | Aneurysm, Intracranial | Aneurysm Cerebral | Aneurysm, Brain | Aneurysm of Cerebral ArteryGermany
-
University of Sao Paulo General HospitalFundação de Amparo à Pesquisa do Estado de São PauloUnknownCerebral Aneurysm | Brain Aneurysm | Aneurysm, Middle Cerebral Artery | Aneurysm, Anterior Communicating Artery | Aneurysm, Posterior Communicating Artery | Aneurysm, Carotid ArteryBrazil
-
Medtronic Neurovascular Clinical AffairsCompletedBrain AneurysmsUnited States, France, Canada, Hungary, Argentina, Italy
-
Microvention-Terumo, Inc.CompletedBrain AneurysmFrance, Germany, Hungary
-
Microvention-Terumo, Inc.Completed
-
Assiut UniversityUnknown
-
Stryker NeurovascularCompletedBrain AneurysmUnited States, Netherlands
-
Medical University of ViennaJohannes Kepler University of LinzUnknown
Clinical Trials on WAVE, as part of the SMART COIL System
-
University Hospital, ToulouseUnknown
-
The Hospital for Sick ChildrenHamilton Health Sciences Corporation; London Health Sciences Centre; Children...Completed
-
Assistance Publique - Hôpitaux de ParisCompletedVentilator WeaningFrance
-
Shalvata Mental Health CenterUnknown
-
Assistance Publique - Hôpitaux de ParisCompleted
-
University of WarwickKing's College London; The Leeds Teaching Hospitals NHS Trust; University Hospitals...Active, not recruitingBreast CancerUnited Kingdom
-
University GhentUniversity Hospital, GhentEnrolling by invitationMild Cognitive ImpairmentBelgium
-
University of AberdeenRecruitingLichen Planus, Oral | Lichen Planus of VulvaUnited Kingdom
-
Centre Hospitalier Universitaire de BesanconRecruitingSARS-CoV-2 InfectionFrance
-
Martini-Klinik am UKE GmbHUniversitätsklinikum Hamburg-EppendorfRecruitingProspective Trial: Myocardial Injury After Noncardiac Surgery (MINS) Following Radical ProstatectomyMyocardial InjuryGermany